Mauss, Stefan; Boeker, Klaus H.; Cornberg, Markus et al.
Effectiveness of DACLATASVIR plus SOFOSBUVIR in HCV-GT3 patients - Results from the German Hepatitis C Registry (DHC-R)HEPATOLOGY. Bd. 63. H. 1 SUPP. 2016 S. 469A-469A
Zimmermann, Tim; Hueppe, Dietrich; Mauss, Stefan et al.
Effects of Smoking on Pegylated Interferon alpha 2a and First Generation Protease Inhibitor-based Antiviral Therapy in Naive Patients Infected with Hepatitis C Virus Genotype 1JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES. Bd. 25. H. 1. 2016 S. 15-24
Ostad, M. A.; Marquardt, E. -M.; Galle, P. R. et al.
ENDOTHELIAL DYSFUNCTION MEASURED BY FLOW MEDIATED DILATATION IN PATIENTS ON THE WAITING LIST AND AFTER LIVER TRANSPLANTATION AS SURROGATE MARKER FOR CARDIOVASCULAR MORTALITYTRANSPLANT INTERNATIONAL. Bd. 29. 2016 S. 24-24
Helmig, S.; Bender, K.; Tug, S. et al.
Exercise-induced cell free DNA in human plasma is predominantly released from cells of the haematopoietic lineageACTA PHYSIOLOGICA. Bd. 216. 2016
Alt, Y.; Schattenberg, J. M.
Expected increase of hepatocellular carcinoma by nonalcoholic fatty liver diseaseZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 54. H. 4. 2016 S. 364-365
Zimmermann, T.; Beckebaum, S.; Berg, C. et al.
Expert recommendations: Hepatitis C and transplantationZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 54. H. 7. 2016 S. 665-684
Galle, Peter Robert
Extended Abstract: Management of Liver CancerDIGESTIVE DISEASES. Bd. 34. H. 4. 2016 S. 438-439
Schattenberg, Joern M.; Lee, Myung-Shik
Extracellular Vesicles as Messengers Between Hepatocytes and Macrophages in Nonalcoholic SteatohepatitisGASTROENTEROLOGY. Bd. 150. H. 4. 2016 S. 815-818
Schwarting, Andreas; Schroeder, Johann O.; Alexander, Tobias et al.
First Real-World Insights into Belimumab Use and Outcomes in Routine Clinical Care of Systemic Lupus Erythematosus in Germany: Results from the OBSErve Germany StudyRHEUMATOLOGY AND THERAPY. Bd. 3. H. 2. 2016 S. 271-290
Stintzing, Sebastian; Modest, Dominik P.; Rossius, Lisa et al.
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trialLANCET ONCOLOGY. Bd. 17. H. 10. 2016 S. 1426-1434